News - Townsend Investments
2nd June 2016 - NovaBiotics Discusses Innovation for Antimicrobial Resistance at BIO

CEO Dr Deborah O’Neil will be presenting in a workshop at this year’s BIO International’s ‘Focus on Anti-Infectives: Innovation for AMR’ in San Francisco, taking place between 6-9 June.

The ‘Focus on Anti-Infectives: Innovation for AMR’ workshop will take place at 11.00am on Monday 6 June in South Room 105 of the Moscone Convention Centre. 

The event will be hosted by the Innovative Medicines’ Initiative (IMI), The Wellcome Trust-funded Community for Open Antimicrobial Drug Discovery and the IMI funded ENABLE project, and will highlight the global tools available to support the development of novel anti-infectives. Its mission is to bring together those involved in all aspects of AMR, including industry large and small, universities, investors, expert scientific and business support, funders, policy makers and regulatory bodies.

Following the workshop, Dr O’Neil will also presenting a 15 minute overview of the Company’s recent progress and future plans at 14.00 on 6 June 2016 in Room 1 of the Moscone Convention Centre. 

NovaBiotics will be taking part in BIO one-to-one partnering throughout the conference and will be available to meet from its pod base within the Scotland Pavilion in the exhibitor hall, Booth 5752.

Go Back